|
|
|
|
|||||
|
|
|
New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the Startup Forum at the Databricks DATA + AI World Tour on October 8, 2025.
The Startup Forum will feature insights from venture capital leaders and early-stage innovators on how they are scaling their companies with Databricks. Mehta will join industry peers including Chris Gervais, CTO of Codametrix, and Stavros Papadopoulos, CEO of TileDB, in a discussion moderated by Tony Pezzullo, Principal at SignalFire. Mehta will share perspectives on Tevogen.AI’s application of advanced data and AI technologies, including its PredicTcell™ platform, developed in collaboration with Microsoft and Databricks, to accelerate precision immunotherapy development.
Databricks DATA + AI World Tour will take place at the Sheraton Boston Hotel. For more information please contact, [email protected]
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b86622e6-99bc-4be9-8b77-537a3cb5e357
| Jan-30 | |
| Jan-29 | |
| Jan-12 | |
| Dec-22 | |
| Dec-19 | |
| Dec-11 | |
| Dec-09 | |
| Dec-08 | |
| Nov-14 | |
| Nov-05 | |
| Nov-03 | |
| Oct-29 | |
| Oct-15 | |
| Sep-25 | |
| Sep-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite